These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

472 related items for PubMed ID: 28065681

  • 1. Mid-regional pro-adrenomedullin in patients with acute dyspnea: Data from the Akershus Cardiac Examination (ACE) 2 Study.
    Pervez MO, Lyngbakken MN, Myhre PL, Brynildsen J, Langsjøen EC, Høiseth AD, Christensen G, Omland T, Røsjø H.
    Clin Biochem; 2017 May; 50(7-8):394-400. PubMed ID: 28065681
    [Abstract] [Full Text] [Related]

  • 2. Mid-regional pro-atrial natriuretic peptide and pro-adrenomedullin testing for the diagnostic and prognostic evaluation of patients with acute dyspnoea.
    Shah RV, Truong QA, Gaggin HK, Pfannkuche J, Hartmann O, Januzzi JL.
    Eur Heart J; 2012 Sep; 33(17):2197-205. PubMed ID: 22645194
    [Abstract] [Full Text] [Related]

  • 3. Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study.
    Pervez MO, Winther JA, Brynildsen J, Strand H, Christensen G, Høiseth AD, Myhre PL, Røysland R, Lyngbakken MN, Omland T, Røsjø H.
    Biomarkers; 2018 Nov; 23(7):654-663. PubMed ID: 29733687
    [Abstract] [Full Text] [Related]

  • 4. Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial.
    Travaglino F, Russo V, De Berardinis B, Numeroso F, Catania P, Cervellin G, Nigra SG, Geraci F, Bressan MA, Guerrini S, Cavazza M, Folli C, Monzani V, Battista S, Mengozzi G, Noto P, Carpinteri G, Semplicini A, Stella F, Ingrassia S, Moscatelli P, Giuntini P, Salerno G, Cardelli P, Di Somma S.
    Am J Emerg Med; 2014 Apr; 32(4):334-41. PubMed ID: 24559907
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of mid-regional pro-atrial natriuretic peptide, procalcitonin, and mid-regional pro-adrenomedullin for the diagnosis and risk stratification of dyspneic ED patients.
    Cinar O, Cevik E, Acar A, Kaya C, Ardic S, Comert B, Yokusoglu M, Bilgi C, Meisner M, Madsen T.
    Am J Emerg Med; 2012 Nov; 30(9):1915-20. PubMed ID: 22742951
    [Abstract] [Full Text] [Related]

  • 6. Multiple biomarker strategy for improved diagnosis of acute heart failure in older patients presenting to the emergency department.
    Bahrmann P, Bahrmann A, Hofner B, Christ M, Achenbach S, Sieber CC, Bertsch T.
    Eur Heart J Acute Cardiovasc Care; 2015 Apr; 4(2):137-47. PubMed ID: 25002708
    [Abstract] [Full Text] [Related]

  • 7. Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
    Maisel A, Mueller C, Nowak RM, Peacock WF, Ponikowski P, Mockel M, Hogan C, Wu AH, Richards M, Clopton P, Filippatos GS, Di Somma S, Anand I, Ng LL, Daniels LB, Neath SX, Christenson R, Potocki M, McCord J, Hartmann O, Morgenthaler NG, Anker SD.
    J Am Coll Cardiol; 2011 Aug 30; 58(10):1057-67. PubMed ID: 21867843
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic performance and reference values of novel biomarkers of paediatric heart failure.
    Hauser JA, Demyanets S, Rusai K, Goritschan C, Weber M, Panesar D, Rindler L, Taylor AM, Marculescu R, Burch M, Wojta J, Michel-Behnke I.
    Heart; 2016 Oct 15; 102(20):1633-9. PubMed ID: 27220692
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
    Khan SQ, O'Brien RJ, Struck J, Quinn P, Morgenthaler N, Squire I, Davies J, Bergmann A, Ng LL.
    J Am Coll Cardiol; 2007 Apr 10; 49(14):1525-32. PubMed ID: 17418290
    [Abstract] [Full Text] [Related]

  • 10. Midregional proadrenomedullin (MR-proADM) in the risk stratification of patients with acute pulmonary embolism.
    Pedowska-Włoszek J, Kostrubiec M, Kurnicka K, Ciurzynski M, Palczewski P, Pruszczyk P.
    Thromb Res; 2013 Nov 10; 132(5):506-10. PubMed ID: 24060192
    [Abstract] [Full Text] [Related]

  • 11. Prognostic potential of midregional pro-adrenomedullin following decompensation for systolic heart failure: comparison with cardiac natriuretic peptides.
    Morbach C, Marx A, Kaspar M, Güder G, Brenner S, Feldmann C, Störk S, Vollert JO, Ertl G, Angermann CE, INH Study Group and the Competence Network Heart Failure.
    Eur J Heart Fail; 2017 Sep 10; 19(9):1166-1175. PubMed ID: 28516504
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of plasma MR-proADM vs NT-proBNP for heart failure in people with type 2 diabetes: the SURDIAGENE prospective study.
    Fraty M, Velho G, Gand E, Fumeron F, Ragot S, Sosner P, Mohammedi K, Gellen B, Saulnier PJ, Halimi JM, Montaigne D, Ducrocq G, Rehman M, Marre M, Roussel R, Hadjadj S, SURDIAGENE Study Group.
    Diabetologia; 2018 Dec 10; 61(12):2643-2653. PubMed ID: 30232509
    [Abstract] [Full Text] [Related]

  • 13. Fibroblast growth factor 23 in patients with acute dyspnea: Data from the Akershus Cardiac Examination (ACE) 2 Study.
    Lyngbakken MN, Pervez MO, Brynildsen J, Pedersen MH, Sølvernes J, Christensen G, Høiseth AD, Omland T, Røsjø H.
    Clin Biochem; 2018 Feb 10; 52():41-47. PubMed ID: 29074091
    [Abstract] [Full Text] [Related]

  • 14. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
    Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, Ponikowski P, Mockel M, Hogan C, Wu AH, Richards M, Clopton P, Filippatos GS, Di Somma S, Anand I, Ng L, Daniels LB, Neath SX, Christenson R, Potocki M, McCord J, Terracciano G, Kremastinos D, Hartmann O, von Haehling S, Bergmann A, Morgenthaler NG, Anker SD.
    J Am Coll Cardiol; 2010 May 11; 55(19):2062-76. PubMed ID: 20447528
    [Abstract] [Full Text] [Related]

  • 15. Midregional proadrenomedullin and growth differentiation factor-15 are not influenced by obesity in heart failure patients.
    Sinning C, Ojeda F, Wild PS, Schnabel RB, Schwarzl M, Ohdah S, Lackner KJ, Pfeiffer N, Michal M, Blettner M, Munzel T, Kempf T, Wollert KC, Kuulasmaa K, Blankenberg S, Salomaa V, Westermann D, Zeller T.
    Clin Res Cardiol; 2017 Jun 11; 106(6):401-410. PubMed ID: 28004184
    [Abstract] [Full Text] [Related]

  • 16. MR-proANP, MR-proADM, and PCT in Patients Presenting with Acute Dyspnea in a Medical Emergency Unit.
    Heining L, Giesa C, Ewig S.
    Lung; 2016 Apr 11; 194(2):185-91. PubMed ID: 26748496
    [Abstract] [Full Text] [Related]

  • 17. Mid-regional pro-adrenomedullin: an indicator of the failing Fontan circuit in patients with univentricular hearts?
    Kaiser R, Abdul-Khaliq H, Wilkens H, Herrmann E, Raedle-Hurst TM.
    Eur J Heart Fail; 2014 Oct 11; 16(10):1082-8. PubMed ID: 25201135
    [Abstract] [Full Text] [Related]

  • 18. Mid-regional pro-atrial natriuretic peptide to predict clinical course in heart failure patients undergoing cardiac resynchronization therapy.
    Arrigo M, Truong QA, Szymonifka J, Rivas-Lasarte M, Tolppanen H, Sadoune M, Gayat E, Cohen-Solal A, Ruschitzka F, Januzzi JL, Singh JP, Mebazaa A.
    Europace; 2017 Nov 01; 19(11):1848-1854. PubMed ID: 28096288
    [Abstract] [Full Text] [Related]

  • 19. Midregional pro-adrenomedullin in addition to b-type natriuretic peptides in the risk stratification of patients with acute dyspnea: an observational study.
    Potocki M, Breidthardt T, Reichlin T, Morgenthaler NG, Bergmann A, Noveanu M, Schaub N, Uthoff H, Freidank H, Buser L, Bingisser R, Christ M, Mebazaa A, Mueller C.
    Crit Care; 2009 Nov 01; 13(4):R122. PubMed ID: 19627611
    [Abstract] [Full Text] [Related]

  • 20. Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes.
    Zabarovskaja S, Hage C, Linde C, Daubert JC, Donal E, Gabrielsen A, Mellbin L, Lund LH.
    Int J Cardiol; 2015 Nov 01; 189():6-11. PubMed ID: 25885866
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.